Close Menu

NEW YORK (GenomeWeb News) – Genizon BioSciences has entered into a partnership with drug development consultancy Speid & Associates to offer that firm's clients access to Genizon's predictive techniques in the drug development process.

Speid's customers will use Genizon's genetic platform to identify and eliminate compounds that have a relatively low chance of success early in the drug development cycle.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.

Aug
29
Sponsored by
PerkinElmer

This webinar will outline how RUCDR Infinite Biologics, the world's largest university-based biorepository, has implemented workflows and processes to support precision medicine applications.